CLOs on the Move

Community Health Resources

www.chrhealth.org

 
Community Health Resources` (CHR) mission is to help adults, children and families find Real Hope for the challenges of Real Life through an array of community based mental health, substance use, child welfare, supported housing, foster care, prevention and wellness services and integrated care. Our name embodies our commitment to community based care, utilizing all available resources to achieve change, and instill hope for a healthy, happy and productive future. CHR is proud to provide services that achieve Real Quality with Real Results. CHR’s history dates back to the 1960s, and since its creation, has become a trusted community ...
  • Number of Employees: 250-1000
  • Annual Revenue: $0-1 Million
  • www.chrhealth.org
  • One Renaissance Blvd.
    Oakbrook Terrace, IL USA 60181
  • Phone: 630.792.5636

Executives

Name Title Contact Details
Angela Rizzolo
 Vice President, Operations, Quality and Compliance Profile

Similar Companies

Prime Medica

Prime Medica is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Long Island Consultation Center

Long Island Consultation Center is a Rego Park, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bonfils Blood Center

Bonfils Blood Center Foundation was established in 1995 as the fundraising arm of Bonfils Blood Center and serves the core function of encouraging and managing philanthropy to support a variety of programs and initiatives for Bonfils Blood Center. From

Action Revenue Recovery

Action Revenue Recovery is a Monroe, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ForSight VISION5

ForSight VISION5, Inc. (www.forsightvision5.com), was founded in January of 2011 as the fifth company to emerge from the ophthalmic incubator ForSight Labs, LLC (www.forsightlabs.com). ForSight VISION5 is focused on developing non-invasive drug delivery products that replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5`s lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to receive medication continually. The Helios insert is restricted to investigational use only and has not been approved by the Food and Drug Administration or any other regulatory authority for commercial distribution.